SynthesisArchives of gynecology and obstetrics2025
Association between obstructive sleep apnea and female sexual dysfunction: a systematic review and meta-analysis.
Synthesis in Archives of gynecology and obstetrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeSexual dysfunction in women with obstructive sleep apnea (OSA) is currently an underappreciated problem. This study aimed to clarify the association between OSA and female sexual dysfunction (FSD) through a systematic review and meta-analysis of existing studies.
methodsWe searched PubMed, Embase, and Cochrane Library databases for clinical observational studies of OSA and FSD from the database inception to November 2024. The outcome measures included the prevalence of FSD and the Female Sexual Function Index (FSFI) score. A random-effects model was utilized to generate pooled odds ratio (OR) and 95% confidence intervals (CI) for FSD prevalence, and standardized mean difference (SMD) and 95% CI for FSFI scores.
resultsThis review included 11 studies, involving 1,317,856 women with OSA and 1,317,899 controls. The overall results showed that OSA was associated with an increased risk of FSD (OR 2.56; 95% CI 1.38-4.75) and lower FSFI scores (SMD - 0.72; 95% CI - 1.24 to - 0.20).
conclusionsFemale sexual dysfunction is associated with OSA, and the prevalence of sexual dysfunction is higher in women with OSA than in the control group. More studies are needed to confirm the association between OSA and sexual dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.